122 related articles for article (PubMed ID: 1572123)
1. SPECT brain imaging in Alzheimer's disease during treatment with oral tetrahydroaminoacridine and lecithin.
Cohen MB; Fitten LJ; Lake RR; Perryman KM; Graham LS; Sevrin R
Clin Nucl Med; 1992 Apr; 17(4):312-5. PubMed ID: 1572123
[TBL] [Abstract][Full Text] [Related]
2. Cerebral perfusion imaging in Alzheimer's disease. Use of single photon emission computed tomography and iofetamine hydrochloride I 123.
Johnson KA; Mueller ST; Walshe TM; English RJ; Holman BL
Arch Neurol; 1987 Feb; 44(2):165-8. PubMed ID: 3492992
[TBL] [Abstract][Full Text] [Related]
3. Tetrahydroaminoacridine-lecithin combination treatment in patients with intermediate-stage Alzheimer's disease. Results of a Canadian double-blind, crossover, multicenter study.
Gauthier S; Bouchard R; Lamontagne A; Bailey P; Bergman H; Ratner J; Tesfaye Y; Saint-Martin M; Bacher Y; Carrier L
N Engl J Med; 1990 May; 322(18):1272-6. PubMed ID: 2183056
[TBL] [Abstract][Full Text] [Related]
4. [Benzodiazepine receptor and cerebral blood flow in early Alzheimer's disease--SPECT study using 123I-iomazenil and 123I-IMP].
Kitamura S; Koshi Y; Komiyama T; Sakayori O; Komaba Y; Ohyama M; Mishina M; Tsuganesawa T; Terashi A
Kaku Igaku; 1996 Jan; 33(1):49-56. PubMed ID: 8819714
[TBL] [Abstract][Full Text] [Related]
5. Tacrine (tetrahydroaminoacridine; THA) and lecithin in senile dementia of the Alzheimer type: a multicentre trial. Groupe Français d'Etude de la Tetrahydroaminoacridine.
Chatellier G; Lacomblez L
BMJ; 1990 Feb; 300(6723):495-9. PubMed ID: 2107926
[TBL] [Abstract][Full Text] [Related]
6. Treatment of Alzheimer's disease with short- and long-term oral THA and lecithin: a double-blind study.
Fitten LJ; Perryman KM; Gross PL; Fine H; Cummins J; Marshall C
Am J Psychiatry; 1990 Feb; 147(2):239-42. PubMed ID: 2405720
[TBL] [Abstract][Full Text] [Related]
7. [Three-dimensional surface display with 123I-IMP brain perfusion imaging in patients with dementia].
Tomino Y; Tachibana H; Sugita M
Rinsho Shinkeigaku; 1994 Apr; 34(4):318-25. PubMed ID: 8026123
[TBL] [Abstract][Full Text] [Related]
8. [Cerebral hemodynamic difference between early- and late-onset Alzheimer's disease by circumferential profile analysis with 123I-IMP brain SPECT].
Arai H; Hanyu H; Abe S; Asano T; Takasaki M; Suzuki T; Abe K; Katsunuma H
Kaku Igaku; 1992 Oct; 29(10):1223-6. PubMed ID: 1464962
[TBL] [Abstract][Full Text] [Related]
9. [Diagnostic imaging of dementia by SPECT].
Hitose K; Tanaka K; Kuroda A; Hamamoto M; Miyazaki T; Uchiyama M; Nagashi M
Seishin Shinkeigaku Zasshi; 1992; 94(10):976-81. PubMed ID: 1289914
[No Abstract] [Full Text] [Related]
10. A comparative I-123 IMP SPECT study in Binswanger's disease and Alzheimer's disease.
Kawabata K; Tachibana H; Sugita M; Fukuchi M
Clin Nucl Med; 1993 Apr; 18(4):329-36. PubMed ID: 8482030
[TBL] [Abstract][Full Text] [Related]
11. Alzheimer's disease in Down's syndrome with SPECT.
Rae-Grant AD; Barbour PJ; Sirotta P; Gross P
Clin Nucl Med; 1991 Jul; 16(7):509-10. PubMed ID: 1834388
[TBL] [Abstract][Full Text] [Related]
12. The clinical utility of visual evaluation of scintigraphic perfusion patterns for Alzheimer's disease using I-123 IMP SPECT.
Ishii K; Mori E; Kitagaki H; Sakamoto S; Yamaji S; Imamura T; Ikejiri Y; Kono M
Clin Nucl Med; 1996 Feb; 21(2):106-10. PubMed ID: 8697677
[TBL] [Abstract][Full Text] [Related]
13. Clinical-physiologic correlates of Alzheimer's disease and frontal lobe dementia.
Jagust WJ; Reed BR; Seab JP; Kramer JH; Budinger TF
Am J Physiol Imaging; 1989; 4(3):89-96. PubMed ID: 2789844
[TBL] [Abstract][Full Text] [Related]
14. Single photon emission computed tomography in Alzheimer's disease. Abnormal iofetamine I 123 uptake reflects dementia severity.
Johnson KA; Holman BL; Mueller SP; Rosen TJ; English R; Nagel JS; Growdon JH
Arch Neurol; 1988 Apr; 45(4):392-6. PubMed ID: 3258512
[TBL] [Abstract][Full Text] [Related]
15. Oral tetrahydroaminoacridine treatment of Alzheimer's disease evaluated clinically and by regional cerebral blood flow and EEG.
Minthon L; Gustafson L; Dalfelt G; Hagberg B; Nilsson K; Risberg J; Rosén I; Seiving B; Wendt PE
Dementia; 1993; 4(1):32-42. PubMed ID: 8358504
[TBL] [Abstract][Full Text] [Related]
16. Iofetamine I 123 single photon emission computed tomography is accurate in the diagnosis of Alzheimer's disease.
Johnson KA; Holman BL; Rosen TJ; Nagel JS; English RJ; Growdon JH
Arch Intern Med; 1990 Apr; 150(4):752-6. PubMed ID: 2327836
[TBL] [Abstract][Full Text] [Related]
17. Tacrine in Alzheimer's disease.
Eagger SA; Levy R; Sahakian BJ
Lancet; 1991 Apr; 337(8748):989-92. PubMed ID: 1673209
[TBL] [Abstract][Full Text] [Related]
18. Frontal dysfunction blocks the therapeutic effect of THA on attention in Alzheimer's disease.
Riekkinen P; Riekkinen M; Soininen H; Kuikka J; Laakso M; Riekkinen P
Neuroreport; 1997 May; 8(8):1845-9. PubMed ID: 9223063
[TBL] [Abstract][Full Text] [Related]
19. [A quantitative study of regional cerebral blood flow in patients with dementia of Alzheimer type using single photon emission computed tomography--clinical application of the IMP autoradiographic method (IMP ARG method)].
Koshi Y; Kitamura S; Komiyama T; Sakayori O; Komaba Y; Ohyama M; Tsuganesawa T; Mishina M; Ishiwata A; Soya H; Nakazawa M; Terashi A
Kaku Igaku; 1996 Sep; 33(9):991-8. PubMed ID: 8921667
[TBL] [Abstract][Full Text] [Related]
20. Brain perfusion imaging in Parkinson's disease and Alzheimer's disease demonstrated by three-dimensional surface display with 123I-iodoamphetamine.
Tachibana H; Kawabata K; Tomino Y; Sugita M; Fukuchi M
Dementia; 1993; 4(6):334-41. PubMed ID: 8136897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
